The tnya stock price forecast is benefiting from favorable sector rotation, as capital flows shift into mid-cap growth equities. Momentum studies show sustained positive divergence in moving averages. So should Tenaya Therapeutics ( NASDAQ:TNYA ) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. The options have a ten-year term with a four-year vesting schedule: 25% vests after one year, followed by monthly vesting of 1/48th of shares. These grants were made under the company's 2024 Inducement Equity Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). Institutional commentary reinforces the tnya stock price forecast’s bullish bias, noting strong retention rates in top mutual fund holdings.